Insufficient scRNA-seq data for expression of GPHB5 at single-cell level.
Insufficient scRNA-seq data for expression of GPHB5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 41% | 1.03 | 1080 / 2642 | 0% | 0 | 0 / 705 |
| muscle | 10% | 0.16 | 82 / 803 | 0% | 0 | 0 / 0 |
| heart | 10% | 0.14 | 83 / 861 | 0% | 0 | 0 / 0 |
| bladder | 10% | 0.14 | 2 / 21 | 0% | 0 | 0 / 504 |
| lung | 5% | 0.08 | 31 / 578 | 3% | 0.40 | 33 / 1155 |
| spleen | 7% | 0.16 | 18 / 241 | 0% | 0 | 0 / 0 |
| thymus | 7% | 0.09 | 47 / 653 | 0% | 0 | 0 / 605 |
| esophagus | 5% | 0.08 | 77 / 1445 | 2% | 0.05 | 3 / 183 |
| liver | 6% | 0.12 | 13 / 226 | 0% | 0.00 | 1 / 406 |
| breast | 5% | 0.09 | 25 / 459 | 0% | 0.01 | 3 / 1118 |
| intestine | 5% | 0.07 | 49 / 966 | 0% | 0.00 | 1 / 527 |
| stomach | 3% | 0.03 | 9 / 359 | 2% | 0.04 | 7 / 286 |
| adrenal gland | 5% | 0.05 | 12 / 258 | 0% | 0 | 0 / 230 |
| uterus | 4% | 0.05 | 7 / 170 | 0% | 0.01 | 2 / 459 |
| kidney | 4% | 0.04 | 4 / 89 | 0% | 0 | 0 / 901 |
| prostate | 4% | 0.07 | 11 / 245 | 0% | 0 | 0 / 502 |
| pancreas | 4% | 0.06 | 14 / 328 | 0% | 0 | 0 / 178 |
| adipose | 4% | 0.06 | 51 / 1204 | 0% | 0 | 0 / 0 |
| skin | 4% | 0.04 | 65 / 1809 | 0% | 0.02 | 2 / 472 |
| blood vessel | 4% | 0.05 | 51 / 1335 | 0% | 0 | 0 / 0 |
| ovary | 3% | 0.04 | 6 / 180 | 0% | 0.01 | 1 / 430 |
| peripheral blood | 3% | 0.05 | 27 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_0002155 | Biological process | regulation of thyroid hormone receptor signaling pathway |
| GO_0007189 | Biological process | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0046982 | Molecular function | protein heterodimerization activity |
| GO_0005179 | Molecular function | hormone activity |
| GO_0031531 | Molecular function | thyrotropin-releasing hormone receptor binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | GPHB5 |
| Protein name | Glycoprotein hormone beta 5 (Glycoprotein-beta 5) GPHB5 protein Glycoprotein hormone beta-5 (Thyrostimulin subunit beta) |
| Synonyms | hCG_1647688 GPB5 ZLUT1 |
| Description | FUNCTION: Functions as a heterodimeric glycoprotein hormone with GPHA2 able to bind and activate the thyroid-stimulating hormone receptor (TSHR), leading to increased cAMP production. Plays a central role in controlling thyroid cell metabolism. . |
| Accessions | Q86YW7 A4IF52 ENST00000621500.2 A0A0F7RPU1 ENST00000314140.2 |